Koa Shoji Holdings Co.,Ltd.
Regarding responses toward achieving management aware of capital costs and stock price (Update)
Updating the recognition of current status, capital cost, and capital efficiency. Redefining the relationship among ROE, PBR, and capital cost, and incorporating enhanced shareholder return, production at the Zaō factory, expansion of sales of new products, and strengthened dividend policy and financial strategy.
Key Figures
- ROE: 12.6% (FY2026 June Term)
- CAPM-based cost of equity: 8–10% range
- PBR: 1.02x at the end of the previous term (above 1.0x)
AI要約
Purpose and background of the update
We decided to update our efforts toward realizing management that is mindful of capital costs and stock price, focusing on current analysis, assessment, and improvement. Based on market valuation indicators (PBR, PER, ROE), we redefine the policy to enhance capital efficiency and strengthen shareholder returns.
Key points and upcoming initiatives
Based on mid- to long-term plans, constructing a high-profit structure through expanded launches of new products in the generic drugs segment and early operation of the Zaō Second Factory in the Pharmaceuticals segment; capital and financial strategies to raise capital cost and capital efficiency; continuation of long-term stable dividends; promotion of growth investments through leveraging financial leverage; strengthening IR activities and advancing sustainability.
Koa Shoji Holdings Co.,Ltd.
Company overview · Stock price · Financial data · All IR
